Sponsor or institution
Clinical trials and research at Hunan Cancer Hospital
As of November 12, 2026, Find a Trial lists 17 clinical trials run by Hunan Cancer Hospital that are recruiting, in China. By phase: Phase 2 (6), Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 17Clinical trials
- 1Country
Newest trials
All recruiting trials (17)
-
Precision navigation to boost cancer screening participation in high-risk communities
This study tests whether a personalized navigation program helps adults aged 45–74 in Chinese communities who are at high risk for several cancers to complete recommended free cancer screenings.
-
Firmonertinib with definitive radiotherapy for unresectable Stage III NSCLC with EGFR uncommon mutations
This trial tests whether adding Firmonertinib to definitive radiotherapy helps people with unresectable Stage III NSCLC that has uncommon EGFR mutations.
-
Shenqi Fuwei Mixture combined with neoadjuvant chemotherapy for locally advanced gastric cancer
We will see if adding Shenqi Fuwei Mixture to perioperative neoadjuvant chemotherapy can reduce recurrence and spread in adults with locally advanced gastric adenocarcinoma.
-
Treatment options after targeted therapy stops working in advanced breast cancer
This study will see how well different treatments work for people with advanced breast cancer who have stopped responding to CDK4/6 inhibitors, PIK3CA inhibitors, or T-DXd.
-
Using immunonutrition to reduce esophagitis in lung cancer patients undergoing radiotherapy
This study is testing if a special nutritional drink can help lung cancer patients undergoing radiation therapy experience less throat irritation.
-
Combining low-dose radiotherapy with chemoimmunotherapy for nasopharyngeal carcinoma with liver metastasis
This study is testing whether adding low-dose radiation to chemotherapy and immunotherapy can help people with nasopharyngeal cancer that has spread to the liver feel better and improve their treatment results.
-
Using Trilaciclib to Protect Bone Marrow in Head and Neck Cancer Patients After Surgery
This study is testing if adding a new drug called trilaciclib to standard treatment after surgery can help protect the bone marrow of patients with advanced head and neck cancer from the harmful effects of chemotherapy.
-
Combination therapy using Anlotinib for HR+ metastatic breast cancer
This study is testing a new combination treatment with anlotinib for women with hormone receptor-positive metastatic breast cancer who haven’t had success with other therapies.
-
Using 18F-FAPI-04 PET imaging for cancer diagnosis and monitoring
This study is testing a new type of imaging called 18F-FAPI-04 PET to see if it can help doctors better diagnose and monitor different kinds of cancer.
-
Comparing imaging techniques for diagnosing gastric cancer
This study is testing if a new type of imaging combined with blood tests can better diagnose gastric cancer and its spread in patients already diagnosed with the disease.
-
Treatment for advanced liver cancer using Cadonilimab and Lenvatinib
This study is testing if a new combination of Cadonilimab, Lenvatinib, and chemotherapy can help people with advanced liver cancer that can't be surgically removed.
-
Combination of UTD1 and capecitabine for treating triple negative breast cancer
This study is testing if combining UTD1 with capecitabine can help people with triple negative breast cancer who didn't fully respond to earlier treatment.
-
Counting Epstein-Barr Virus DNA in Blood for Nasopharyngeal Carcinoma Patients
This study is testing a new blood test to see if counting Epstein-Barr Virus DNA can help doctors better monitor treatment responses in patients with nasopharyngeal carcinoma.
-
Combining CDK4/6 inhibitors with hormone therapy and what comes next for HR+/HER2- metastatic breast cancer
This study will see how different follow-up treatments work after progression on CDK4/6 inhibitors plus hormone therapy in people with HR+/HER2- metastatic breast cancer.
-
Combining Sugemalimab with Chemotherapy for Advanced Lung Cancer
This study is testing if combining a new drug called Sugemalimab with chemotherapy can help people with advanced lung cancer that can't be surgically removed feel better and improve their chances of recovery.
-
Combining UTD1 and Capecitabine for HER2-negative Breast Cancer with Brain Metastases
This study is testing if a new treatment combining UTD1 and Capecitabine can help people with HER2-negative breast cancer that has spread to the brain.
-
Evaluating tumor cell characteristics in breast cancer patients
This study is testing if tracking certain tumor cells in breast cancer patients can help predict how well they respond to treatment after chemotherapy and surgery.
Quick answers
How many clinical trials run by Hunan Cancer Hospital are recruiting right now?
17, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 6, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.